Genome-Wide Binding of MBD2 Reveals Strong Preference for Highly Methylated Loci

MBD2 is a subunit of the NuRD complex that is postulated to mediate gene repression via recruitment of the complex to methylated DNA. In this study we adopted an MBD2 tagging-approach to study its genome wide binding characteristics. We show that in vivo MBD2 is mainly recruited to CpG island promoters that are highly methylated. Interestingly, MBD2 binds around 1 kb downstream of the transcription start site of a subset of ∼400 CpG island promoters that are characterized by the presence of active histone marks, RNA polymerase II (Pol2) and low to medium gene expression levels and H3K36me3 deposition. These tagged-MBD2 binding sites in MCF-7 show increased methylation in a cohort of primary breast cancers but not in normal breast samples, suggesting a putative role for MBD2 in breast cancer.

[1]  J. Lis,et al.  Genome-wide dynamics of Pol II elongation and its interplay with promoter proximal pausing, chromatin, and exons , 2014, eLife.

[2]  T. E. Wilson,et al.  Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications , 2014, Genome research.

[3]  Huidong Shi,et al.  MBD3 Localizes at Promoters, Gene Bodies and Enhancers of Active Genes , 2013, PLoS genetics.

[4]  Bishnu Bhattacharyya,et al.  Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. , 2013, Carcinogenesis.

[5]  M. Gut,et al.  Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. , 2013, Cell stem cell.

[6]  Chengyu Liu,et al.  Integrative Analysis of Deep Sequencing Data Identifies Estrogen Receptor Early Response Genes and Links ATAD3B to Poor Survival in Breast Cancer , 2013, PLoS Comput. Biol..

[7]  F. Lienert,et al.  Methylation-Dependent and -Independent Genomic Targeting Principles of the MBD Protein Family , 2013, Cell.

[8]  M. Scharfe,et al.  Differential roles for MBD2 and MBD3 at methylated CpG islands, active promoters and binding to exon sequences , 2013, Nucleic acids research.

[9]  Anthony A. Hyman,et al.  Stoichiometry of chromatin-associated protein complexes revealed by label-free quantitative mass spectrometry-based proteomics , 2012, Nucleic acids research.

[10]  Yong Zhang,et al.  Identifying ChIP-seq enrichment using MACS , 2012, Nature Protocols.

[11]  H. Stunnenberg,et al.  The Human EKC/KEOPS Complex Is Recruited to Cullin2 Ubiquitin Ligases by the Human Tumour Antigen PRAME , 2012, PloS one.

[12]  P. Defossez,et al.  The role of methyl-binding proteins in chromatin organization and epigenome maintenance. , 2012, Briefings in functional genomics.

[13]  Brian J. Stevenson,et al.  Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. , 2012, Genome research.

[14]  H. Stunnenberg,et al.  The tumour antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promoters , 2011, The EMBO journal.

[15]  Erwin G. Van Meir,et al.  Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. , 2011, Cancer research.

[16]  A. Bird,et al.  CpG islands and the regulation of transcription. , 2011, Genes & development.

[17]  M. Mann,et al.  Extracting gene function from protein-protein interactions using Quantitative BAC InteraCtomics (QUBIC). , 2011, Methods.

[18]  P. Defossez,et al.  The Human Proteins MBD5 and MBD6 Associate with Heterochromatin but They Do Not Bind Methylated DNA , 2010, PloS one.

[19]  A. Hyman,et al.  Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions , 2010, The Journal of cell biology.

[20]  G. Tsujimoto,et al.  Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing , 2010, BMC Genomics.

[21]  Madeleine P. Ball,et al.  Corrigendum: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells , 2009, Nature Biotechnology.

[22]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[23]  A. Bird,et al.  MBD2-Mediated Transcriptional Repression of the p14ARF Tumor Suppressor Gene in Human Colon Cancer Cells , 2008, Pathobiology.

[24]  Michael B. Stadler,et al.  Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. , 2008, Molecular cell.

[25]  A. Bird,et al.  Mbd2 Contributes to DNA Methylation-Directed Repression of the Xist Gene , 2007, Molecular and Cellular Biology.

[26]  A. Chess,et al.  Gene Body-Specific Methylation on the Active X Chromosome , 2007, Science.

[27]  H. Stunnenberg,et al.  Histone modification patterns associated with the human X chromosome , 2006, EMBO reports.

[28]  A. Bird,et al.  Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.

[29]  Hendrik G. Stunnenberg,et al.  MBD2/NuRD and MBD3/NuRD, Two Distinct Complexes with Different Biochemical and Functional Properties , 2006, Molecular and Cellular Biology.

[30]  G. Blobel,et al.  Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. , 2005, Molecular cell.

[31]  U. Bunz.  How Are Alkynes Scrambled? , 2005, Science.

[32]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[33]  E. Cho,et al.  Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. , 2000, Genes & development.

[34]  K D Robertson,et al.  DNA methylation: past, present and future directions. , 2000, Carcinogenesis.

[35]  A. Bird,et al.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. , 1999, Genes & development.

[36]  E. Wagner,et al.  Imprinted expression of the Igf2r gene depends on an intronic CpG island , 1997, Nature.

[37]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[38]  B. Migeon,et al.  Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[40]  R Holliday,et al.  DNA modification mechanisms and gene activity during development , 1975, Science.

[41]  A. Brasier,et al.  Two-step cross-linking for analysis of protein-chromatin interactions. , 2012, Methods in molecular biology.

[42]  A. Bird,et al.  MBD 2-Mediated Transcriptional Repression of the p 14 ARF Tumor Suppressor Gene in Human Colon Cancer Cells , 2008 .

[43]  H. Cedar,et al.  Gamete–specific methylation correlates with imprinting of the murine Xist gene , 1995, Nature Genetics.

[44]  A. Bird,et al.  Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins , 2022 .